Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics
- PMID: 20375732
- PMCID: PMC4419691
- DOI: 10.1097/DBP.0b013e3181d5aa6d
Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics
Abstract
Objective: We assessed the prevalence of autism spectrum disorders (ASD) and screening test characteristics in children with Down syndrome.
Method: Eligible children born in a defined geographic area between January 1, 1996, and December 31, 2003, were recruited through a population-based birth defects registry and community outreach, then screened with the modified checklist for autism in toddlers or social communication questionnaire, as appropriate. Screen-positive children and a random sample of screen-negative children underwent developmental evaluation.
Results: We screened 123 children (27.8% of the birth cohort). Mean age was 73.4 months (range, 31-142). Compared to screen-negative children, screen-positive children had similar sociodemographic characteristics but a lower mean developmental quotient (mean difference: 11.0; 95% confidence interval: 4.8-17.3). Weighted prevalences of autistic disorder and total ASD were 6.4% (95% confidence interval [CI]: 2.6%-11.6%) and 18.2% (95% CI: 9.7%-26.8%), respectively. The estimated minimum ASD prevalence, accounting for unscreened children, is 5.1% (95% CI: 3.3%-7.4%). ASD prevalence increased with greater cognitive impairment. Screening test sensitivity was 87.5% (95% CI: 66.6%-97.7%); specificity was 49.9% (95% CI: 37.0%-61.4%).
Conclusion: The prevalence of ASD among children with Down syndrome aged 2 to 11 years is substantially higher than in the general population. The modified checklist for autism in toddlers and social communication questionnaire were highly sensitive in children with Down syndrome but could result in many false positive tests if universal screening were implemented using current algorithms. Research needs include development of specific ASD screening algorithms and improved diagnostic discrimination in children with Down syndrome. Timely identification of these co-occurring diagnoses is essential so appropriate interventions can be provided.
Figures
Comment in
-
Autism spectrum disorder in Down syndrome: definition of the cutoff point for the autism screening questionnaire screening instrument.J Dev Behav Pediatr. 2010 Oct;31(8):684. doi: 10.1097/DBP.0b013e3181f4a067. J Dev Behav Pediatr. 2010. PMID: 20924246 No abstract available.
Similar articles
-
A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample.J Am Acad Child Adolesc Psychiatry. 2014 May;53(5):500-8. doi: 10.1016/j.jaac.2013.12.021. Epub 2014 Jan 21. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 24745950 Free PMC article.
-
An initial evaluation of the Social Communication Questionnaire for the assessment of autism spectrum disorders in children with Down syndrome.J Dev Behav Pediatr. 2012 Feb;33(2):134-45. doi: 10.1097/DBP.0b013e318240d3d9. J Dev Behav Pediatr. 2012. PMID: 22267105
-
Screening children with neurofibromatosis type 1 for autism spectrum disorder.Am J Med Genet A. 2014 Jul;164A(7):1706-12. doi: 10.1002/ajmg.a.36549. Epub 2014 Apr 8. Am J Med Genet A. 2014. PMID: 24715629
-
The clinician's guide to autism.Pediatr Rev. 2014 Feb;35(2):62-78; quiz 78. doi: 10.1542/pir.35-2-62. Pediatr Rev. 2014. PMID: 24488830 Review.
-
Autism and Down syndrome: early identification and diagnosis.Arq Neuropsiquiatr. 2022 Jun;80(6):620-630. doi: 10.1590/0004-282X-ANP-2021-0156. Arq Neuropsiquiatr. 2022. PMID: 35946706 Free PMC article.
Cited by
-
Considerations for measuring individual outcomes across contexts in Down syndrome: Implications for research and clinical trials.Int Rev Res Dev Disabil. 2022;62:191-225. doi: 10.1016/bs.irrdd.2022.05.005. Epub 2022 Aug 19. Int Rev Res Dev Disabil. 2022. PMID: 36213318 Free PMC article.
-
Vasopressin in the Amelioration of Social Functioning in Autism Spectrum Disorder.J Clin Med. 2019 Jul 19;8(7):1061. doi: 10.3390/jcm8071061. J Clin Med. 2019. PMID: 31331023 Free PMC article. Review.
-
Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients.Neuropsychiatr Dis Treat. 2019 Sep 20;15:2723-2741. doi: 10.2147/NDT.S210613. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31571888 Free PMC article.
-
Similar Gap-Overlap Profiles in Children with Fragile X Syndrome and IQ-Matched Autism.J Autism Dev Disord. 2025 Mar;55(3):891-903. doi: 10.1007/s10803-024-06245-1. Epub 2024 Jan 21. J Autism Dev Disord. 2025. PMID: 38246961
-
Sensory Responsiveness Is Linked With Communication in Infant Siblings of Children With and Without Autism.J Speech Lang Hear Res. 2021 Jun 4;64(6):1964-1976. doi: 10.1044/2021_JSLHR-20-00196. Epub 2021 May 18. J Speech Lang Hear Res. 2021. PMID: 34003699 Free PMC article.
References
-
- Reilly C. Autism spectrum disorders in Down syndrome: a review. Res Autism Spectr Disord. 2009;3:829–839.
-
- Kent L, Evans J, Paul M, Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol. 1999;41:153–158. - PubMed
-
- Lowenthal R, Paula CS, Schwartzman JS, Brunoni D, Mercadante MT. Prevalence of pervasive developmental disorder in Down's syndrome. J Autism Dev Disord. 2007;37:1394–1395. - PubMed
-
- Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55:468–479. - PubMed
-
- Ozonoff S, Goodlin-Jones BL, Solomon M. Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol. 2005;34:523–540. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical